{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:09:45Z","timestamp":1788772185279,"version":"build-2803163510"},"reference-count":30,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.25122\/jml-2026-0071","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:34:15Z","timestamp":1788770055000},"page":"387-395","source":"Crossref","is-referenced-by-count":0,"title":["Segmental and global amyloid burden and myocardial mechanics: a multimodality imaging comparison"],"prefix":"10.25122","volume":"19","author":[{"given":"Claudiu","family":"Stan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Nuclear Medicine and Ultrasonography, Fundeni Clinical Institute, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Neculae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Cardiology, Expert Center for Rare Genetic Cardiovascular Diseases, Prof. Dr. C.C. Iliescu Emergency Institute for Cardiovascular Diseases, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Onciul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Cardiology, Floreasca Emergency Clinical Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Daniel","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Cardiology, Expert Center for Rare Genetic Cardiovascular Diseases, Prof. Dr. C.C. Iliescu Emergency Institute for Cardiovascular Diseases, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Andrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Cardiology, Expert Center for Rare Genetic Cardiovascular Diseases, Prof. Dr. C.C. Iliescu Emergency Institute for Cardiovascular Diseases, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razvan","family":"Cap\u015fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Radiology, Fundeni Clinical Institute, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Jercan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Hematology, Fundeni Clinical Institute, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorina","family":"Badelita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Hematology, Fundeni Clinical Institute, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Coriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Hematology, Fundeni Clinical Institute, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxandra","family":"Jurcu\u0163","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Cardiology, Expert Center for Rare Genetic Cardiovascular Diseases, Prof. Dr. C.C. Iliescu Emergency Institute for Cardiovascular Diseases, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10755","reference":[{"issue":"4","key":"ref1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/13506129.2024.2405948","article-title":"Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee","volume":"31","author":"Buxbaum JN, Eisenberg DS, F\u00e4ndrich M, McPhail ED, Merlini G, Saraiva MJM","year":"2024","unstructured":"1. Buxbaum JN, Eisenberg DS, F\u00e4ndrich M, McPhail ED, Merlini G, Saraiva MJM, Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee, Amyloid, 2024;31(4):249-256","journal-title":"Amyloid"},{"issue":"12","key":"ref2","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy","volume":"68","author":"Falk RH, Alexander KM, Liao R, Dorbala S","year":"2016","unstructured":"2. Falk RH, Alexander KM, Liao R, Dorbala S, AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy, J Am Coll Cardiol, 2016;68(12):1323-41","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"ref3","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg FL, Berk JL","year":"2012","unstructured":"3. Ruberg FL, Berk JL, Transthyretin (TTR) cardiac amyloidosis, Circulation, 2012;126(10):1286-300","journal-title":"Circulation"},{"key":"ref4","article-title":"XIIIth International Symposium on Amyloidosis 2012: \u201cFrom misfolded proteins to well-designed treatment\u201d [Internet]","author":"Hazenberg BPC, Bijzet J","year":"2012","unstructured":"4. Hazenberg BPC, Bijzet J, XIIIth International Symposium on Amyloidosis 2012: \u201cFrom misfolded proteins to well-designed treatment\u201d [Internet], 2012;Available from: https:\/\/www.researchgate.net\/publication\/260086782_XIIIth_International_Symposium_on_Amyloidosis_2012_From_misfolded_proteins_to_well-designed_treatment"},{"issue":"1","key":"ref5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13023-020-1309-9","article-title":"Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population","volume":"15","author":"Jercan A, Ene A, Jurcut R, Draghici M, Badelita S, Dragomir M","year":"2020","unstructured":"5. Jercan A, Ene A, Jurcut R, Draghici M, Badelita S, Dragomir M, Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population, Orphanet J Rare Dis, 2020;15(1):34","journal-title":"Orphanet J Rare Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"132714","DOI":"10.1016\/j.ijcard.2024.132714","article-title":"A phenotypic comparison of the Romanian and French ATTRv cohorts: Glu54Gln founder pathogenic variant vs the most common variants in Western Europe","volume":"419","author":"Neculae G, Zaroui A, Kharoubi M, B\u00e9zard M, Funalot B, Adam R","year":"2025","unstructured":"6. Neculae G, Zaroui A, Kharoubi M, B\u00e9zard M, Funalot B, Adam R, A phenotypic comparison of the Romanian and French ATTRv cohorts: Glu54Gln founder pathogenic variant vs the most common variants in Western Europe, Int J Cardiol, 2025;419132714","journal-title":"Int J Cardiol"},{"issue":"11","key":"ref7","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.3390\/jcm14113734","article-title":"Diagnostic Accuracy of Bisphosphonate Scintigraphy in Glu54GlnATTR Cardiomyopathy","volume":"14","author":"Stan C, Neculae G, Adam RD, Jercan A, Badelita SN, Draghici MR","year":"2025","unstructured":"7. Stan C, Neculae G, Adam RD, Jercan A, Badelita SN, Draghici MR, Diagnostic Accuracy of Bisphosphonate Scintigraphy in Glu54GlnATTR Cardiomyopathy, J Clin Med, 2025;14(11):3734","journal-title":"J Clin Med"},{"issue":"6","key":"ref8","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging","volume":"26","author":"Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA","year":"2019","unstructured":"8. Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging, J Nucl Cardiol, 2019;26(6):2065-2123Erratum in: J Nucl Cardiol. 2021 Aug;28(4). 1761-1762. doi: 10.1007\/s12350-021-02711-w","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"ref9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s12350-019-01761-5","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization","volume":"27","author":"Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA","year":"2020","unstructured":"9. Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization, J Nucl Cardiol, 2020;27(2):659-673Erratum in: J Nucl Cardiol. 2021 Aug;28(4);1763-1767. doi: 10.1007\/s12350-021-02712-9","journal-title":"J Nucl Cardiol"},{"issue":"7","key":"ref10","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cardfail.2021.06.012","article-title":"Addendum to ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging","volume":"28","author":"Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA","year":"2022","unstructured":"10. Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Addendum to ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging, J Card Fail, 2022;28(7):e1-e4Epub 2021 Jul 1. Erratum for: J Card Fail. 2019 Nov 25;11:e1-e39. doi: 10.1016\/j.cardfail.2019.08.001","journal-title":"J Card Fail"},{"issue":"16","key":"ref11","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A","year":"2021","unstructured":"11. Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases, Eur Heart J, 2021;42(16):1554-1568","journal-title":"Eur Heart J"},{"issue":"5","key":"ref12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jacc.2025.09.004","article-title":"Transthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical Guidance","volume":"87","author":"Writing Committee; Kittleson MM, Ambardekar AV, Cheng RK, Griffin JM, Maurer MS, Nativi-Nicolau J, Ruberg FL","year":"2026","unstructured":"12. Writing Committee; Kittleson MM, Ambardekar AV, Cheng RK, Griffin JM, Maurer MS, Nativi-Nicolau J, Ruberg FL, Transthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical Guidance, J Am Coll Cardiol, 2026;87(5):549-565","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"iii7","DOI":"10.1093\/eurheartjsupp\/suaf036","article-title":"Present and future of endomyocardial biopsy in cardiac amyloidosis","volume":"27","author":"Grasso M, Cavaliere C, Vilardo V, Tagliani M, Di Toro A, Urtis M","year":"2025","unstructured":"13. Grasso M, Cavaliere C, Vilardo V, Tagliani M, Di Toro A, Urtis M, Present and future of endomyocardial biopsy in cardiac amyloidosis, Eur Heart J Suppl, 2025;27(Suppl 3):iii7-iii12","journal-title":"Eur Heart J Suppl"},{"issue":"6","key":"ref14","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.jcmg.2020.03.020","article-title":"DPD Quantification in Cardiac Amyloidosis: A Novel Imaging Biomarker","volume":"13","author":"Scully PR, Morris E, Patel KP, Treibel TA, Burniston M, Klotz E","year":"2020","unstructured":"14. Scully PR, Morris E, Patel KP, Treibel TA, Burniston M, Klotz E, DPD Quantification in Cardiac Amyloidosis: A Novel Imaging Biomarker, JACC Cardiovasc Imaging, 2020;13(6):1353-1363","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"ref15","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini E, Guidalotti PL, Salvi F, Cooke RM, Pettinato C, Riva L","year":"2005","unstructured":"15. Perugini E, Guidalotti PL, Salvi F, Cooke RM, Pettinato C, Riva L, Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy, J Am Coll Cardiol, 2005;46(6):1076-84","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"ref16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","article-title":"Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review","volume":"18","author":"Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S","year":"2016","unstructured":"16. Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S, Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review, J Cardiovasc Magn Reson, 2016;18(1):89","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"106773","DOI":"10.1016\/j.ejim.2026.106773","article-title":"How to monitor disease progression in ATTR amyloid cardiomyopathy: Implications for clinical practice and trial design","author":"Porcari A, Cuddy SA, Metra M, Emdin M, Fontana M, Gillmore JD","year":"2026","unstructured":"17. Porcari A, Cuddy SA, Metra M, Emdin M, Fontana M, Gillmore JD, How to monitor disease progression in ATTR amyloid cardiomyopathy: Implications for clinical practice and trial design, Eur J Intern Med, 2026;106773","journal-title":"Eur J Intern Med"},{"issue":"3","key":"ref18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/13506129.2018.1520087","article-title":"Quantitation of 99mTc-DPD uptake in patients with transthyretin-related cardiac amyloidosis","volume":"25","author":"Ross JC, Hutt DF, Burniston M, Page J, Steeden JA, Gillmore JD","year":"2018","unstructured":"18. Ross JC, Hutt DF, Burniston M, Page J, Steeden JA, Gillmore JD, Quantitation of 99mTc-DPD uptake in patients with transthyretin-related cardiac amyloidosis, Amyloid, 2018;25(3):203-210","journal-title":"Amyloid"},{"issue":"1","key":"ref19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s41824-018-0035-1","article-title":"Tc-HDP quantitative SPECT\/CT in transthyretin cardiac amyloid and the development of a reference interval for myocardial uptake in the non-affected population","volume":"2","author":"Ramsay SC, Lindsay K, Fong W, Patford S, Younger J, Atherton J","year":"2018","unstructured":"19. Ramsay SC, Lindsay K, Fong W, Patford S, Younger J, Atherton J, Tc-HDP quantitative SPECT\/CT in transthyretin cardiac amyloid and the development of a reference interval for myocardial uptake in the non-affected population, Eur J Hybrid Imaging, 2018;2(1):17","journal-title":"Eur J Hybrid Imaging"},{"issue":"5","key":"ref20","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1007\/s12350-019-01893-8","article-title":"Quantitative 99mTc-DPD SPECT\/CT in patients with suspected ATTR cardiac amyloidosis: Feasibility and correlation with visual scores","volume":"27","author":"Caobelli F, Braun M, Haaf P, Wild D, Zellweger MJ","year":"2020","unstructured":"20. Caobelli F, Braun M, Haaf P, Wild D, Zellweger MJ, Quantitative 99mTc-DPD SPECT\/CT in patients with suspected ATTR cardiac amyloidosis: Feasibility and correlation with visual scores, J Nucl Cardiol, 2020;27(5):1456-1463","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"ref21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12350-022-02960-3","article-title":"Quantitative 99mTc-DPD-SPECT\/CT assessment of cardiac amyloidosis","volume":"30","author":"Kessler L, Fragoso Costa P, Kersting D, Jentzen W, Weber M, L\u00fcdike P, Carpinteiro A, Oubari S, Hagenacker T, Thimm A, Rassaf T, Herrmann K, Papathanasiou M, Rischpler C","year":"2023","unstructured":"21. Kessler L, Fragoso Costa P, Kersting D, Jentzen W, Weber M, L\u00fcdike P, Carpinteiro A, Oubari S, Hagenacker T, Thimm A, Rassaf T, Herrmann K, Papathanasiou M, Rischpler C, Quantitative 99mTc-DPD-SPECT\/CT assessment of cardiac amyloidosis, J Nucl Cardiol, 2023;30(1):101-111","journal-title":"J Nucl Cardiol"},{"issue":"3","key":"ref22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3109\/13506129.2013.797890","article-title":"Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis","volume":"20","author":"Ihse E, Rapezzi C, Merlini G, Benson MD, Ando Y, Suhr OB","year":"2013","unstructured":"22. Ihse E, Rapezzi C, Merlini G, Benson MD, Ando Y, Suhr OB, Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis, Amyloid, 2013;20(3):142-50","journal-title":"Amyloid"},{"issue":"1","key":"ref23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/03009734.2015.1122687","article-title":"(99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis","volume":"121","author":"Pilebro B, Suhr OB, N\u00e4slund U, Westermark P, Lindqvist P, Sundstr\u00f6m T","year":"2016","unstructured":"23. Pilebro B, Suhr OB, N\u00e4slund U, Westermark P, Lindqvist P, Sundstr\u00f6m T, (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis, Ups J Med Sci, 2016;121(1):17-24","journal-title":"Ups J Med Sci"},{"issue":"44","key":"ref24","doi-asserted-by":"publisher","first-page":"26430","DOI":"10.1074\/jbc.R115.653097","article-title":"Specific chaperones and regulatory domains in control of amyloid formation","volume":"290","author":"Landreh M, Rising A, Presto J, J\u00f6rnvall H, Johansson J","year":"2015","unstructured":"24. Landreh M, Rising A, Presto J, J\u00f6rnvall H, Johansson J, Specific chaperones and regulatory domains in control of amyloid formation, J Biol Chem, 2015;290(44):26430-6","journal-title":"J Biol Chem"},{"issue":"12","key":"ref25","doi-asserted-by":"publisher","first-page":"e024717","DOI":"10.1161\/JAHA.121.024717","article-title":"Correlation Between Cardiac Images, Biomarkers, and Amyloid Load in Wild-Type Transthyretin Amyloid Cardiomyopathy","volume":"11","author":"Morioka M, Takashio S, Nakashima N, Nishi M, Fujiyama A, Hirakawa K","year":"2022","unstructured":"25. Morioka M, Takashio S, Nakashima N, Nishi M, Fujiyama A, Hirakawa K, Correlation Between Cardiac Images, Biomarkers, and Amyloid Load in Wild-Type Transthyretin Amyloid Cardiomyopathy, J Am Heart Assoc, 2022;11(12):e024717","journal-title":"J Am Heart Assoc"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"s30","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac amyloidosis","volume":"18","author":"Martinez-Naharro A, Hawkins PN, Fontana M","year":"2018","unstructured":"26. Martinez-Naharro A, Hawkins PN, Fontana M, Cardiac amyloidosis, Clin Med (Lond), 2018;18(Suppl 2):s30-s35","journal-title":"Clin Med (Lond)"},{"issue":"19","key":"ref27","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan D, Collier P, Thavendiranathan P, Popovi\u0107 ZB, Hanna M, Plana JC","year":"2012","unstructured":"27. Phelan D, Collier P, Thavendiranathan P, Popovi\u0107 ZB, Hanna M, Plana JC, Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis, Heart, 2012;98(19):1442-8","journal-title":"Heart"},{"issue":"14","key":"ref28","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/eurheartj\/ehz905","article-title":"Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis","volume":"41","author":"Chacko L, Martone R, Bandera F, Lane T, Martinez-Naharro A, Boldrini M","year":"2020","unstructured":"28. Chacko L, Martone R, Bandera F, Lane T, Martinez-Naharro A, Boldrini M, Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis, Eur Heart J, 2020;41(14):1439-1447","journal-title":"Eur Heart J"},{"issue":"5","key":"ref29","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1001\/jamacardio.2019.0849","article-title":"Association of patisiran, an RNA interference therapeutic, with regional left ventricular myocardial strain in hereditary transthyretin amyloidosis: the APOLLO study","volume":"4","author":"Minamisawa M, Claggett B, Adams D, Kristen AV, Merlini G, Slama MS","year":"2019","unstructured":"29. Minamisawa M, Claggett B, Adams D, Kristen AV, Merlini G, Slama MS, Association of patisiran, an RNA interference therapeutic, with regional left ventricular myocardial strain in hereditary transthyretin amyloidosis: the APOLLO study, JAMA Cardiol, 2019;4(5):466-472","journal-title":"JAMA Cardiol"},{"issue":"7 Pt 1","key":"ref30","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.jcmg.2018.06.016","article-title":"Relative Apical Sparing of Myocardial Longitudinal Strain Is Explained by Regional Differences in Total Amyloid Mass Rather Than the Proportion of Amyloid Deposits","volume":"12","author":"Bravo PE, Fujikura K, Kijewski MF, Jerosch-Herold M, Jacob S, El-Sady MS","year":"2019","unstructured":"30. Bravo PE, Fujikura K, Kijewski MF, Jerosch-Herold M, Jacob S, El-Sady MS, Relative Apical Sparing of Myocardial Longitudinal Strain Is Explained by Regional Differences in Total Amyloid Mass Rather Than the Proportion of Amyloid Deposits, JACC Cardiovasc Imaging, 2019;12(7 Pt 1):1165-1173","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2026\/issue-5-2026\/original-article-issue-5-2026\/segmental-and-global-amyloid-burden-and-myocardial-mechanics-a-multimodality-imaging-comparison\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:34:27Z","timestamp":1788770067000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2026\/issue-5-2026\/original-article-issue-5-2026\/segmental-and-global-amyloid-burden-and-myocardial-mechanics-a-multimodality-imaging-comparison\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["JMedLife-19-387"],"URL":"https:\/\/doi.org\/10.25122\/jml-2026-0071","relation":{},"ISSN":["1844-3117"],"issn-type":[{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}